Northern Trust
LYEL icon

Northern Trust’s Lyell Immunopharma LYEL Stock Holding History

Northern Trust’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
118,500
+88,220
+291% +$1.6M ﹤0.01% 3242
2026
Q1 		$607K Hold
30,280
– – ﹤0.01% 3537
2025
Q4 		$932K Buy
30,280
+2,152
+8% +$48.2K ﹤0.01% 3415
2025
Q3 		$457K Buy
28,128
+9,484
+51% +$108K ﹤0.01% 3682
2025
Q2 		$165K Sell
18,644
-46,110
-71% -$420K ﹤0.01% 3998
2025
Q1 		$697K Sell
64,754
-757
-1% -$9.27K ﹤0.01% 3432
2024
Q4 		$839K Sell
65,511
-2,293
-3% -$45.5K ﹤0.01% 3463
2024
Q3 		$1.87M Sell
67,804
-1,648
-2% -$48.4K ﹤0.01% 3048
2024
Q2 		$2.01M Sell
69,452
-2,647
-4% -$126K ﹤0.01% 2895
2024
Q1 		$3.22M Sell
72,099
-1,676
-2% -$71.8K ﹤0.01% 2736
2023
Q4 		$2.86M Sell
73,775
-384
-0.5% -$13.8K ﹤0.01% 2802
2023
Q3 		$2.18M Buy
74,159
+2,446
+3% +$116K ﹤0.01% 2893
2023
Q2 		$4.56M Sell
71,713
-14,826
-17% -$820K ﹤0.01% 2554
2023
Q1 		$4.08M Sell
86,539
-22,888
-21% -$1.22M ﹤0.01% 2580
2022
Q4 		$7.59M Buy
109,427
+7,491
+7% +$744K ﹤0.01% 2199
2022
Q3 		$14.9M Buy
101,936
+41,722
+69% +$5.65M ﹤0.01% 1695
2022
Q2 		$7.85M Buy
60,214
+7,593
+14% +$776K ﹤0.01% 2208
2022
Q1 		$5.32M Buy
52,621
+42,042
+397% +$5.09M ﹤0.01% 2550
2021
Q4 		$1.64M Sell
10,579
-113
-1% -$25.2K ﹤0.01% 3321
2021
Q3 		$3.17M Buy
+10,692
New +$3.2M ﹤0.01% 3030

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Northern Trust's LYEL Position: Q2 2026 in Review

Northern Trust increased its Lyell Immunopharma (LYEL) stake by 291% in Q2 2026, buying an estimated $1.6M and bringing the position to 118,500 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Northern Trust first reported a position in LYEL in Q3 2021 and has held it in 20 quarters since. The position peaked at $14.9M in Q3 2022. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Northern Trust held 118,500 shares of Lyell Immunopharma worth $1.66M as of Q2 2026.
  • Northern Trust bought 88,220 Lyell Immunopharma shares in Q2 2026, an estimated $1.6M.
  • Lyell Immunopharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3242 holding.
  • Northern Trust first reported a position in Lyell Immunopharma in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's Lyell Immunopharma position peaked at $14.9M in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.